A two-day workshop on Newcastle disease (ND) control in West and Central Africa brought together 38 representatives from the government and private sectors to discuss key challenges and potential interventions in the vaccine delivery and administration in the regions. The event, which ran from 29-30 June 2017 in Ouagadougou, Burkina Faso, included presentations, discussions and […]
July 6th: Today is World Zoonoses Day – a date that has particular relevance in light of the global Brucellosis Vaccine Prize, a US $30 million prize competition inviting vaccine developers to submit proposals for – and ultimately develop – a suitable vaccine for use against Brucella melitensis in small ruminants across the developing world. […]
On June 8, 2017, the Global Alliance for Livestock Veterinary Medicines (GALVmed) convened a workshop in Kampala, Uganda, aimed at presenting the findings on the safety and protection of East Coast Fever-Infection Treatment Method (ECF-ITM) vaccine at farm level in the country. The findings were from an on-farm ECF-ITM study in Uganda supported by GALVmed […]
GALVmed recently held a workshop Nairobi (19-20 January 2017) to discuss ongoing research to improve the East Coast Fever (ECF) vaccine. The vaccine, commonly known as Infection and Treatment Method (ITM) was developed in mid-70s and since then new tools have been developed to characterise the vaccine strains/stocks and provide new knowledge to make it […]
Rwandan farmers will soon have a reason to smile as they will be able to protect their cattle from one of the deadliest cattle diseases – East Coast Fever. The disease that kills numerous cattle across the East Africa region is present in most regions of Rwanda and yet unlike their East African counterparts, Rwandan […]
A new US $30 million initiative was launched in June 2016 to offer a solution to a sheep and goat disease that is transmitted to over 500,000 people per year worldwide. The prize is one of the largest of its kind and is funded by AgResults, a collaborative multi-donor initiative between the Australian, Canadian, UK and US governments […]
What’s your reaction to the US $30m Brucellosis prize competition and that it’s funded by the private sector? Gwyn Jones, Chairman of the Responsible Use of Medicines in Agriculture Alliance (RUMA) UK responds with his personal view. —————————————————————————————————- GALVmed and AgResults announced the launch of the Brucellosis Vaccine Initiative, a US $30 million prize competition […]
What’s your reaction to the US $30m Brucellosis prize competition and that it’s funded by the private sector? Peter Oostenbach, Associate Director for Global Public Policy Animal Health at Merck Animal Health/MSD Animal Health responds with his personal view. —————————————————————————————————- GALVmed and AgResults announced the launch of the Brucellosis Vaccine Initiative, a US $30 million […]
Why is a vaccine against B. melitensis important? George Tice, Senior Director of Market Access for Europe, Middle East and Africa at Elanco Animal Health responds with his personal view. —————————————————————————————————- GALVmed and AgResults announced the launch of the Brucellosis Vaccine Initiative, a US $30 million prize competition aimed at incentivising animal health companies to […]
If the Brucellosis Vaccine Prize Competition results in a vaccine, do you think companies could start looking at diseases that remain untreated? Brigitte Boenisch, Head of Regulatory Affairs for Europe, Middle East and Africa at Merial responds with her personal view. —————————————————————————————————- GALVmed and AgResults announced the launch of the Brucellosis Vaccine Initiative, a US […]